Sinco Pharmaceuticals Holdings Ltd. Statistics
Want to see HK:6833 full AI Analyst Report?
Sinco Pharmaceuticals Holdings Ltd. (6833) Stock Statistics & Valuation Metrics
Total Valuation
Sinco Pharmaceuticals Holdings Ltd. has a market cap or net worth of HKD 237.85M. The enterprise value is HKD 164.08M.
- Market Cap
- HKD 237.85M
- Enterprise Value
- HKD 164.08M
Share Statistics
Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,032,890,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Sinco Pharmaceuticals Holdings Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.92%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 5.92%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 8.11M
- Profits Per Employee
- 135.61K
- Employee Count
- 257
- Asset Turnover
- 1.13
- Inventory Turnover
- 7.17
Valuation Ratios
The current PE Ratio of Sinco Pharmaceuticals Holdings Ltd. is 6.44. Sinco Pharmaceuticals Holdings Ltd.’s PEG ratio is -0.24.
- PE Ratio
- 6.44
- PS Ratio
- 0.10
- PB Ratio
- 0.27
- Price to FCF
- 0.63
- Price to Operating Cash Flow
- 0.62
- PEG Ratio
- -0.24
Income Statement
In the last 12 months, Sinco Pharmaceuticals Holdings Ltd. had revenue of 2.08B and earned 34.85M in profits. Earnings per share was 0.02.
- Revenue
- 2.08B
- Gross Profit
- 222.09M
- Operating Income
- 72.00M
- Pretax Income
- 48.26M
- Net Income
- 34.85M
- EBITDA
- 99.83M
- Earnings Per Share (EPS)
- 0.02
Cash Flow
In the last 12 months, operating cash flow was 313.45M and capital expenditures -8.45M, giving a free cash flow of 305.00M billion.
- Operating Cash Flow
- 313.45M
- Free Cash Flow
- 305.00M
- Free Cash Flow per Share
- 0.15
Dividends & Yields
Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HKD 0.00, resulting in a dividend yield of 1.43%
- Dividend Per Share
- HKD 0.00
- Dividend Yield
- 1.43%
- Payout Ratio
- 8.70%
- Free Cash Flow Yield
- 157.47%
- Earnings Yield
- 15.69%
Stock Price Statistics
- Beta
- -0.20
- 52-Week Price Change
- -41.21%
- 50-Day Moving Average
- 0.14
- 200-Day Moving Average
- 0.17
- Relative Strength Index (RSI)
- 35.48
- Average Volume (3m)
- 182.91K
Important Dates
Sinco Pharmaceuticals Holdings Ltd. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- May 19, 2025
Financial Position
Sinco Pharmaceuticals Holdings Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 26.42%
- Current Ratio
- 1.18
- Quick Ratio
- 0.95
- Debt to Market Cap
- 0.57
- Net Debt to EBITDA
- -1.91
- Interest Coverage Ratio
- 2.18
Taxes
In the past 12 months, Sinco Pharmaceuticals Holdings Ltd. has paid 13.41M in taxes.
- Income Tax
- 13.41M
- Effective Tax Rate
- 0.28
Enterprise Valuation
Sinco Pharmaceuticals Holdings Ltd. EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.19.
- EV to Sales
- -0.03
- EV to EBITDA
- -0.65
- EV to Free Cash Flow
- -0.19
- EV to Operating Cash Flow
- -0.19
Balance Sheet
Sinco Pharmaceuticals Holdings Ltd. has HKD 369.41M in cash and marketable securities with HKD 116.76M in debt, giving a net cash position of HKD 252.65M billion.
- Cash & Marketable Securities
- HKD 369.41M
- Total Debt
- HKD 116.76M
- Net Cash
- HKD 252.65M
- Net Cash Per Share
- HKD 0.12
- Tangible Book Value Per Share
- HKD 0.29
Margins
Gross margin is 11.12%, with operating margin of 2.79%, and net profit margin of 1.58%.
- Gross Margin
- 11.12%
- Operating Margin
- 2.79%
- Pretax Margin
- 2.18%
- Net Profit Margin
- 1.58%
- EBITDA Margin
- 4.71%
- EBIT Margin
- 3.31%
Analyst Forecast
The average price target for Sinco Pharmaceuticals Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -20.04%
- EPS Growth Forecast
- -25.66%
Scores
- Smart Score
- ―
- AI Score
- 52

